| Effect of oral naltrexone on pruritus in cholestatic patients F Mansour-Ghanaei, A Taheri, H Froutan, H Ghofrani, M Nasiri-Toosi, ... World journal of gastroenterology: WJG 12 (7), 1125, 2006 | 115 | 2006 |
| A Triple Blinded, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis: a Pilot Study. S Rahimpour, M Nasiri-Toosi, H Khalili, NE Daryani, MK Nouri Taromlou, ... Journal of Gastrointestinal & Liver Diseases 25 (4), 2016 | 97 | 2016 |
| Disturbances of parathyroid hormone–vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study A Miroliaee, M Nasiri-Toosi, O Khalilzadeh, A Esteghamati, A Abdollahi, ... Hepatology international 4, 634-640, 2010 | 91 | 2010 |
| Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease F Bokharaei‐Salim, H Keyvani, SHR Monavari, SM Alavian, Z Madjd, ... Journal of Medical Virology 83 (6), 989-995, 2011 | 80 | 2011 |
| A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue JJ Theal, MN Toosi, L Girlan, RJ Heslegrave, PM Huet, KW Burak, ... Hepatology 41 (6), 1305-1312, 2005 | 76 | 2005 |
| Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis A Shah, D Crawford, D Burger, N Martin, M Walker, NJ Talley, C Tallis, ... Seminars in Liver Disease 39 (04), 432-441, 2019 | 66 | 2019 |
| Potential therapeutic applications for Terminalia chebula in Iranian traditional medicine A Jokar, F Masoomi, O Sadeghpour, M Nassiri-Toosi, S Hamedi Journal of Traditional Chinese Medicine 36 (2), 250-254, 2016 | 64 | 2016 |
| Clinical and chest CT features as a predictive tool for COVID-19 clinical progress: introducing a novel semi-quantitative scoring system F Salahshour, MM Mehrabinejad, M Nassiri Toosi, M Gity, H Ghanaati, ... European radiology 31, 5178-5188, 2021 | 57 | 2021 |
| Occult hepatitis C virus infection in candidates for liver transplant with cryptogenic cirrhosis H Keyvani, F Bokharaei-Salim, SH Monavari, M Esghaei, MN Toosi, ... Hepatitis Monthly 13 (8), 2013 | 53 | 2013 |
| Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time K Samimi-Rad, M Nasiri Toosi, A Masoudi-Nejad, A Najafi, R Rahimnia, ... Archives of virology 157, 1959-1965, 2012 | 53 | 2012 |
| Clinical characteristics and outcomes of 905 COVID-19 patients admitted to Imam Khomeini hospital complex in the capital city of Tehran, Iran SF Allameh, S Nemati, R Ghalehtaki, E Mohammadnejad, SM Aghili, ... Archives of Iranian medicine 23 (11), 766-775, 2020 | 41 | 2020 |
| Factors influencing health self-management in adherence to care and treatment among the recipients of liver transplantation MSM Mohssen Nassiri toosi Patient Preference and Adherence 12, 2425, 2018 | 41 | 2018 |
| Pancreatic pseudotumor with sclerosing pancreato-cholangitis: is this a systemic disease? MN Toosi, J Heathcote Official journal of the American College of Gastroenterology| ACG 99 (2 …, 2004 | 38 | 2004 |
| Safety and efficacy of locally manufactured pegylated interferon in hepatitis C patients H JABARI, AA BAYATIAN, AH Sharifi, RH ZAER, E Fakharzadeh, R Asadi, ... ARCHIVES OF IRANIAN MEDICINE 13 (4), 306-312, 2010 | 34 | 2010 |
| Prevalence and severity of depression in chronic viral hepatitis in Iran M Mirabdolhagh Hazaveh, T Dormohammadi Toosi, M Nasiri Toosi, ... Gastroenterology Report 3 (3), 234-237, 2015 | 33 | 2015 |
| Imaging and imaging-guided interventions in the diagnosis and management of hepatocellular carcinoma (HCC)-review of evidence H Ghanaati, SM Alavian, A Jafarian, NE Daryani, M Nassiri-Toosi, ... Iranian Journal of Radiology 9 (4), 167, 2012 | 32 | 2012 |
| Management of liver hemangioma using trans-catheter arterial embolization K Firouznia, H Ghanaati, SM Alavian, MN Toosi, NE Daryani, AH Jalali, ... Hepatitis monthly 14 (12), 2014 | 31 | 2014 |
| Perspective of placenta derived mesenchymal stem cells in acute liver failure M Saleh, M Taher, AA Sohrabpour, AA Vaezi, M Nasiri Toosi, ... Cell & bioscience 10, 1-11, 2020 | 29 | 2020 |
| Potential nephrotoxicity of sofosbuvir-based treatment in patients infected with hepatitis C virus: a review on incidence, type and risk factors. NTM Dashti-Khavidaki S, Khalili H Expert Rev Clin Pharmacol. 11 (5), 525, 2018 | 29 | 2018 |
| Psychosocial status of liver transplant candidates in Iran and its correlation with health-related quality of life and depression and anxiety M Banihashemi, M Hafezi, M Nasiri-Toosi, A Jafarian, MR Abbasi, ... Journal of transplantation 2015, 2015 | 28 | 2015 |
